American Portfolios Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
Other funds holding PJP
PAM
FDCDDQ
American Portfolios Advisors's PJP Position: Q3 2022 in Review
American Portfolios Advisors reduced its Invesco Pharmaceuticals ETF (PJP) stake by 5.3% in Q3 2022, selling an estimated $14.2K and leaving 3,400 shares worth $242K. The position accounts for 0.01% of the portfolio, ranked #948.
American Portfolios Advisors first reported a position in PJP in Q4 2017 and has held it in 20 quarters since. The position peaked at $302K in Q4 2021. 81 funds tracked by Wall St. Rank hold PJP as of Q3 2022.
- American Portfolios Advisors held 3,400 shares of Invesco Pharmaceuticals ETF worth $242K as of Q3 2022.
- American Portfolios Advisors sold 191 Invesco Pharmaceuticals ETF shares in Q3 2022, an estimated $14.2K.
- Invesco Pharmaceuticals ETF made up 0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #948 holding.
- American Portfolios Advisors first reported a position in Invesco Pharmaceuticals ETF in Q4 2017 and has held it in 20 quarters since.
- American Portfolios Advisors's Invesco Pharmaceuticals ETF position peaked at $302K in Q4 2021.
- 81 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2022.
Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.